Finance

Lists
688073:SHA
Bide Pharmatech Co Ltd
CNยฅ63.30
+1.59%
(+0.99) 1D
Nov 17, 3:00:01โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688073...
Open
CNยฅ62.00
High
CNยฅ64.90
Low
CNยฅ62.00
Mkt. cap
5.66B
Avg. vol.
4.47M
Volume
2.36M
Dividend
1.83%
Quarterly dividend
CNยฅ0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
27.78
52-wk high
CNยฅ88.88
52-wk low
CNยฅ43.21
EPS
CNยฅ2.28
No. of employees
734
Open
CNยฅ62.00
High
CNยฅ64.90
Low
CNยฅ62.00
Mkt. cap
5.66B
Avg. vol.
4.47M
Volume
2.36M
Dividend
1.83%
Quarterly dividend
CNยฅ0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
27.78
52-wk high
CNยฅ88.88
52-wk low
CNยฅ43.21
EPS
CNยฅ2.28
No. of employees
734
News stories
From web sources and news partners
About Bide Pharmatech Co Ltd
CEO-
Employees734
FoundedApr 27, 2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
344.70M
323.28M
359.56M
368.43M
Cost of goods sold
229.41M
165.25M
194.66M
168.35M
Cost of revenue
229.41M
165.25M
194.66M
168.35M
Research and development expenses
13.41M
14.99M
13.27M
19.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.46M
68.86M
71.92M
68.07M
Operating expense
110.37M
81.39M
94.89M
83.18M
Total operating expenses
339.78M
246.63M
289.55M
251.53M
Operating income
4.92M
76.64M
70.01M
116.90M
Other non operating income
7.57M
-15.67M
13.87M
-30.55M
EBT including unusual items
35.86M
61.38M
75.58M
71.15M
EBT excluding unusual items
-1.67M
64.07M
62.13M
107.02M
Income tax expense
3.86M
14.55M
19.10M
10.52M
Effective tax rate
10.75%
23.71%
25.27%
14.78%
Other operating expenses
11.14M
-3.21M
7.06M
-2.64M
Net income
32.01M
46.83M
56.47M
60.63M
Net profit margin
9.29%
14.49%
15.71%
16.46%
Earnings per share
-
-
-
-
Interest and investment income
4.95M
4.19M
4.60M
2.10M
Interest expense
-1.18M
-1.10M
-1.00M
-6.78M
Net interest expenses
3.78M
3.10M
3.60M
-4.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.47M
80.20M
73.76M
120.45M
Gain or loss from assets sale
-3.90M
-
-4.84M
4.84M
Upcoming events
AI content may include mistakes. Learn more
Google apps